Adimmune

Founded in 1965, Adimmune Corporation(Stock code: 4142.TW)  is the only influenza vaccine manufacturer with both EU GMP and US FDA certificates in Taiwan. Their major products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, Japanese Encephalitis Vaccine (JEV), Tetanus Toxoid, and purified Tuberculin. Adimmune supports Sanofi Pasteur (France) in the commercialization of the recombinant protein quadrivalent influenza vaccine in the United States. They also cooperate with Shenzhen Techdow (China) to produce low-molecular enoxaparin sodium. The capacity further enlarges to other areas as our Cell Culture Production Plant received Taiwan FDA GMP Certificate in 2022, making Adimmune the only certificated vaccine company in the country.